Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Administrative data

Endpoint:
acute toxicity: oral
Type of information:
experimental study
Adequacy of study:
key study
Reliability:
2 (reliable with restrictions)
Rationale for reliability incl. deficiencies:
other: Comparable to guideline methods with acceptable restrictions - analytical purity of test article was not given in the report

Data source

Reference
Reference Type:
study report
Title:
Unnamed
Year:
1978
Report date:
1978

Materials and methods

Test guideline
Qualifier:
equivalent or similar to guideline
Guideline:
OECD Guideline 401 (Acute Oral Toxicity)
Deviations:
yes
Remarks:
(dosing volume > 10 mL/kg bw, 10/14 hour light/dark cycle, acclimation period = 4 days)
GLP compliance:
no
Test type:
standard acute method
Limit test:
no

Test material

Constituent 1
Chemical structure
Reference substance name:
2-(2H-benzotriazol-2-yl)-4,6-bis(1-methyl-1-phenylethyl)phenol
EC Number:
274-570-6
EC Name:
2-(2H-benzotriazol-2-yl)-4,6-bis(1-methyl-1-phenylethyl)phenol
Cas Number:
70321-86-7
Molecular formula:
C30H29N3O
IUPAC Name:
2-(2H-1,2,3-benzotriazol-2-yl)-4,6-bis(2-phenylpropan-2-yl)phenol
Test material form:
solid
Details on test material:
- Name as cited in publication: 2 - [2' hydroxy - 3', 5' - bis- (alpha, aplha dimethylbenzyl) phenyl]-benzotriazole
- Batch number: A 16-234/5
- Analytical purity: no data
- Physical state: solid

Specific details on test material used for the study:
- Name as cited in publication: 2 - [2' hydroxy - 3', 5' - bis- (alpha, aplha dimethylbenzyl) phenyl]-benzotriazole
- Batch number: A 16-234/5
- Analytical purity: no data
- Physical state: solid

Test animals

Species:
rat
Strain:
other: Tif RAI f (SPF)
Sex:
male/female
Details on test animals or test system and environmental conditions:
TEST ANIMALS
- Source: Ciba Geigy Ltd.
- Age: 7 to 8 wks
- Mean weight range at study initiation: 173 - 187 g (♂) and 175 - 184 g (♀)
- Fasting period before study: overnight
- Housing: 5/cage (macrolon cages type V)
- Diet: ad libitum; NAFAG Gossau SG
- Water: ad libitum
- Acclimation period: 4 days

ENVIRONMENTAL CONDITIONS
- Temperature (°C): 22 ± 1
- Humidity (%): 55 ± 5
- Photoperiod (hrs dark / hrs light): 14/10

Administration / exposure

Route of administration:
oral: gavage
Vehicle:
polyethylene glycol
Remarks:
(400)
Details on oral exposure:
VEHICLE
- Concentration in vehicle: 10, 20, 30 %
- Amount of vehicle (if gavage): no data
- Justification for choice of vehicle: Test substance is insoluble in water

MAXIMUM DOSE VOLUME APPLIED: 10 - 25.8 mL/kg bw

DOSAGE PREPARATION
A test substance suspension was prepared. Before treatment the suspension was homogeneously dispersed with an Ultra-Turrax and during treatment it was kept stable with a magnetic stirrer.
Doses:
1,000, 2,150, 4,640 and 7,750 mg/kg bw
No. of animals per sex per dose:
5
Control animals:
no
Details on study design:
- Duration of observation period following administration: 14 days
- Frequency of observations: Physical condition and rate of deaths were monitored throughout the whole observation period.
- Frequency of weighing: body weights were recorded immediately prior to dosing (control weights) and 7 and 14 days post treatment
- Necropsy of survivors performed: yes

Results and discussion

Effect levels
Sex:
male/female
Dose descriptor:
LD50
Effect level:
> 7 750 mg/kg bw
Based on:
test mat.
Remarks on result:
other: Highest dose tested. Mortality did not occur in any dose group.
Mortality:
No mortality was detected in any group
Clinical signs:
other: - 1,000 mg/kg bw: sedation, dyspnoea, exophthalmos, ruffled fur and curved body position (symptoms starting as early as 1 hour post dosing, fully reversible within 8 days) - 2,150 and 4,640mg/kg bw: sedation, dyspnoea, exophthalmos, ruffled fur and curved
Gross pathology:
No substance related gross organ changes were seen at the necropsy of sacrificed animals

Any other information on results incl. tables

Table 1: Table of Body weights (acute oral toxicity)

 

 

Dose (mg/kg bw)

 

 

1,000

2,150

4,640

7,750

Day 1

187 ± 7.1

173 ± 2.3

175 ± 3.7

181 ± 1.6

184 ± 4.1

179 ± 1.3

175 ± 2.8

163 ± 4.5

Day 7

251 ± 9.6

233 ± 9.8

250 ± 8.3

237 ± 1.8

219 ± 6.1

216 ± 5.2

210 ± 7.5

194 ± 6.6

Day 14

289 ± 17.0

285 ± 11.6

298 ± 17.2

288 ± 8.7

248 ± 7.0

239 ± 4.0

233 ± 9.7

217 ± 7.0

Applicant's summary and conclusion

Interpretation of results:
GHS criteria not met